Latest News about SLN
Recent news which mentions SLN
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Top 3 Health Care Stocks You'll Regret Missing In Q4
November 19, 2024
From Benzinga
Tickers
SLN
From InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
From InvestorPlace
From InvestorPlace
Tickers
SLN
From InvestorPlace
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
April 11, 2024
From InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
From InvestorPlace
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
March 14, 2024
From Benzinga
What's Going On With Silence Therapeutics Stock Today?
March 13, 2024
From Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
From Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
From Benzinga
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
January 31, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
From Benzinga
Is This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidate
November 01, 2023
Tickers
SLN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 01, 2023
From Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 25, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free